TNF and obesity due to melanocortin 4 receptor deficiency: Moreover, obesity has been shown to impair the efficacy of psoriasis treatments, particularly fixed-dose biologics like TNF inhibitors, likely due to altered pharmacokinetics and increased systemic inflammation [9].